首页
400-620-6333
应用
选项
-
Palivizumab (anti-RSV-F)简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 呼吸道合胞病毒(Respiratory syncytial virus) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 188039-54-5
-
Nirsevimab (anti-RSV)简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 呼吸道合胞病毒(Respiratory syncytial virus) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1989556-22-0SMILES: [Nirsevimab]
-
Diridavumab (anti-HA)简短描述: Purity≥95% Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level≤1.0EU/mg; Human IgG1-REM; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 甲型流感(Influenza A) 亚型: Human IgG1-REM宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1393659-46-5
-
Suptavumab (anti-RSV-F )简短描述: Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated种属反应性: 呼吸道合胞病毒(Respiratory syncytial virus) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1629615-23-1SMILES: [Suptavumab]
-
Navivumab (anti-HA)简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 甲型流感(Influenza A) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1443004-16-7
